Skip to content

Founder & Director

Dr Amit Verma

MBBS | Residency (MD) | MRCP (UK) | MRCP (UK) SCE Medical Oncology | ESMO Medical Oncology

Precision Oncology • Medical Oncology • Molecular Oncology • Cancer Genetics

Dr Amit Verma, Molecular Oncologist and Founder & Director of Dr AV Institute, Gurugram

Profile

About Dr Amit Verma

Dr Amit Verma is an oncologist and physician-scientist with specialist expertise in precision oncology, medical oncology, molecular oncology, cancer genetics and translational cancer research.

His training spans India, the United States and Europe: AIIMS New Delhi, UT MD Anderson Cancer Center, Sidney Kimmel Cancer Center–Jefferson Health, the Royal College of Physicians (UK), the European Society for Medical Oncology (ESMO), and the University of Geneva.

His clinical and research work focuses on integrating tumour biology, molecular diagnostics, genomic profiling, biomarkers, cancer genetics and clinical evidence to support individualized cancer-care decisions.

Areas of Expertise

Credentials

Qualifications & Training

2026

CPM — Precision Medicine

University of Geneva, Switzerland

2024

MRCP (UK) SCE Medical Oncology

Royal College of Physicians, UK

2024

ESMO Medical Oncology

European Society for Medical Oncology

2023–2025

MRCP (UK) Internal Medicine

Royal College of Physicians, London

2023

ACMO — Molecular Oncology

Sidney Kimmel Cancer Center / Jefferson Health, Thomas Jefferson University, Philadelphia

2008–2009

Clinical Internship — Internal Medicine

UT Health Science Center, Houston

2005–2007

Fellowship — Experimental Therapeutics / Cancer Medicine

UT MD Anderson Cancer Center, Houston

2002–2004

Residency (MD) — Biochemistry / Cancer Medicine

AIIMS, New Delhi

1995–2001

MBBS

SMS Medical College, Rajasthan

Beyond India

International Training

UT MD Anderson Cancer Center

Houston, Texas, USA

Fellowship in Experimental Therapeutics / Cancer Medicine

2005–2007

UT Health Science Center

Houston, Texas, USA

Clinical Internship — Internal Medicine

2008–2009

Sidney Kimmel Cancer Center / Jefferson Health

Thomas Jefferson University, Philadelphia, USA

ACMO — Molecular Oncology

2023

Royal College of Physicians, UK

United Kingdom

MRCP (UK) Internal Medicine; MRCP (UK) SCE Medical Oncology

2023–2025

European Society for Medical Oncology

Switzerland

ESMO Medical Oncology

2024

University of Geneva

Switzerland

CPM — Precision Medicine

2026

International Certifications

  • ECFMG — Educational Commission for Foreign Medical Graduates, Philadelphia, USA (2007)
  • Writing and Publishing Scientific Articles — MD Anderson Cancer Center, Houston, USA (2006)
  • Safe Handling of Radioactive Materials in Research and Clinical Laboratories — MD Anderson Cancer Center, Houston, USA (2005)

Today

Current Leadership Roles

Since 2021

Founder & Director

Dr AV Institute of Personalized Cancer Treatment and Research, Gurugram

Since 2025

Director — Precision Oncology

Karkinos Healthcare Pvt. Ltd., Mumbai

Since 2012

Chief Medical Director

Molecular Quest Healthcare Pvt. Ltd., Gurugram

Since 2019

Director — Scientific Affairs

Pathkits Healthcare Pvt. Ltd., Gurugram

Experience

Selected Previous Appointments

  • 2012–2021

    Principal Consultant — Molecular Oncology & Cancer Genetics

    Max Institute of Cancer Care, Delhi

    In charge of the Personalized Cancer Medicine Clinic and the Familial Cancer Clinic

  • 2011–2012

    Director — Research & Development and Bio-repository; Senior Consultant — Molecular Oncology & Cancer Genetics

    HealthCare Global Oncology Hospital, Bangalore

  • 2010–2011

    Head & Senior Consultant — Molecular Oncology

    International Oncology / Fortis, Noida

  • 2008–2009

    Physician — Internal Medicine

    UT Health Science Center at Houston, USA

  • 2007–2008

    Consultant — Genetic Medicine

    Sir Ganga Ram Hospital, New Delhi

  • 2005–2007

    Fellow — Experimental Therapeutics

    UT MD Anderson Cancer Center, Houston, USA

  • 2002–2004

    Resident

    AIIMS, New Delhi

Leadership

Clinical & Research Leadership

Dr Verma's work spans clinical oncology, molecular oncology, cancer genetics and translational research. His professional experience includes the development and clinical application of comprehensive genomic profiling, Molecular Tumor Board discussion, hereditary cancer evaluation and precision-oncology approaches.

He has served as Principal Investigator and Co-Investigator in clinical studies involving molecular profiling, precision cancer medicine and systemic cancer therapy.

Medical Registrations

Medical registrations listed in Dr Amit Verma’s professional CV.

India

  • Delhi Medical CouncilRegistration: DMC/R/693
  • Haryana Medical CouncilRegistration: HMC 5246

United Kingdom

  • General Medical Council, United KingdomRegistration: 8173465

Affiliations

Professional Memberships & Affiliations

  • Molecular Pathology Association of India (MPAI)
  • Delhi Molecular Oncology Group / Oncology Forum
  • Molecular Oncology Society (MOS)
  • Indian Cooperative Oncology Group (ICON)
  • Indian Society of Medical and Paediatric Oncology (ISMPO)
  • European Society for Medical Oncology (ESMO)

Academic & Research

47 publications & published abstracts

26 peer-reviewed articles, 7 invited articles and 14 published abstracts.

26
Peer-reviewed articles
7
Invited articles / reviews
14
Published abstracts
4
Book chapters
5
Completed clinical trials as investigator
1
US patent

Selected Publications

Targeting the Untargetable: [161Tb]Tb-FAP-2286 in Young-Onset Refractory Cholangiocarcinoma

Indian Journal of Nuclear Medicine, 2026

ISMPO Guidelines for Diagnosis and Management of Early Breast Cancer

Indian Journal of Medical and Paediatric Oncology, 2025

Liquid Biopsy and Colorectal Cancer

South Asian Journal of Cancer, 2025

Resistance to PARP Inhibitors and Its Clinical Implications

International Journal of Molecular & Immuno Oncology, 2022

Genetic Counseling, Testing, and Management of Hereditary Breast and Ovarian Cancer in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology

JCO Global Oncology, 2020

Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics

iScience, 2020

View all publications →

Selected Recognition

  • Bharat Shree Award (2025)
  • Top 10 AIIMS Delhi Alumni Leaders — CEO Insights (2023)
  • Ramalingaswamy Fellowship Award — Department of Biotechnology, Government of India (2007)
  • Young Scientist Award (2007)
  • Geeta Mittal Gold Medal — AIIMS, New Delhi (2005)

Media & professional insights

View Media Centre →

Read more about the Precision Oncology approach at the institute.

Discuss Your Cancer Care with Dr Amit Verma

For consultation, second opinion, precision-oncology evaluation or review of molecular and genomic findings.

CallRequest a ConsultationSecond Opinion